These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Nonrandom catabolism of proteins in the formation of antigenic peptide fragments. Thomas DW, Schauster JL, Hoffman MD, Wilner GD. J Immunol; 1985 Aug; 135(2):1259-63. PubMed ID: 3874235 [Abstract] [Full Text] [Related]
3. Properties of fibrinogen-antigenic material on the rheumatoid synovial membrane and in the rheumatoid synovial fluid. Clemmensen I, Andersen RB. J Lab Clin Med; 1978 Nov; 92(5):678-89. PubMed ID: 712203 [Abstract] [Full Text] [Related]
4. Antigenic structure of human and bovine fibrinogen and their fibrinogenolytic degradation products. KOCHWA S, JONATHAN-ASSA S, STRAUSS A, KAUFMANN H, DE VRIES A. Bull Res Counc Isr Sect E Exp Med; 1959 Oct; 8E():69-71. PubMed ID: 13853424 [No Abstract] [Full Text] [Related]
5. [The behaviour of fibrinogen and fibrinogen degradation products in myocardial infarction. Justification of a prognostic index (author's transl)]. Abizanda Campos R, Forner Sánchez N, Carrió Soldevilla M, Florit Serra J. Med Clin (Barc); 1979 Dec 15; 73(10):429-34. PubMed ID: 529865 [Abstract] [Full Text] [Related]
7. Evaluation of the fibrinogen antigenic turbidimetric assay as a screening method for measurement of fibrinogen concentration in dogs. Ludwig P, Leidinger EF, Hooijberg EH. Vet Clin Pathol; 2012 Jun 15; 41(2):243-8. PubMed ID: 22551158 [Abstract] [Full Text] [Related]
8. Immunobiology of fibrinogen. Emergence of neoantigenic expressions during physiologic cleavage in vitro and in vivo. Plow E, Edgington TS. J Clin Invest; 1973 Feb 15; 52(2):273-82. PubMed ID: 4119160 [Abstract] [Full Text] [Related]
9. The fibrinogen antigenic turbidimetric assay (FIATA): the X2x test--the corrected chi-square comparison against the control-mean. Stief TW. Clin Appl Thromb Hemost; 2007 Jan 15; 13(1):73-100. PubMed ID: 17164498 [Abstract] [Full Text] [Related]
10. [Antigenic properties of fibrinogen]. Cierniewski C, Krajewski T. Postepy Hig Med Dosw; 1973 Jan 15; 27(4):483-97. PubMed ID: 4126038 [No Abstract] [Full Text] [Related]
11. [Action on human fibrinogen of anti-sera against fibrinogen dissociated chains (author's transl)]. Soria J, Soria C, Boulard C. Pathol Biol (Paris); 1976 Dec 15; 24 Suppl():11-4. PubMed ID: 64957 [Abstract] [Full Text] [Related]
12. Two antipeptide monoclonal antibodies that recognize adhesive sequences in fibrinogen: identification of antigenic determinants and unrelated sequences using synthetic combinatorial libraries. Pinilla C, Buencamino J, Appel JR, Houghten RA, Brassard JA, Ruggeri ZM. Biomed Pept Proteins Nucleic Acids; 1995 Dec 15; 1(3):199-204. PubMed ID: 9346853 [Abstract] [Full Text] [Related]
13. Common antigenic sites in human, bovine and porcine fibrinogens. Cierniewski CS. Thromb Haemost; 1981 Apr 30; 45(2):169-72. PubMed ID: 6167008 [Abstract] [Full Text] [Related]
14. Fluorescence polarization analysis of antigen determinant peptides of human fibrinogen. Köszegi T, Kellermayer M, Jobst K. Acta Biochim Biophys Acad Sci Hung; 1984 Apr 30; 19(3-4):160-75. PubMed ID: 6085852 [Abstract] [Full Text] [Related]
16. [Monoclonal antibodies against fibrinogen and fibrin and against their proteolytic degradation products]. Dyr JE, Cajthamlová H, Suttnar J. Cas Lek Cesk; 1990 Oct 26; 129(43):1349-51. PubMed ID: 2249231 [Abstract] [Full Text] [Related]